As the world’s definitive test of fitness, CrossFit Games competitions stand not only as testaments to the athletes who compete, but to the training methodologies they use. In this arena, a true and honest comparison of training practices and athletic capacity is impossible without a level playing field. Therefore, the use of banned performance-enhancing substances is prohibited under the requirements outlined in the official CrossFit Games Drug Testing Policy.
The Drug Testing Policy aims to prevent the use of prohibited substances through rigorous testing. CrossFit uses a combination of directed and random in-competition and out-of-competition drug testing to deter athletes from using prohibited performance-enhancing substances and detect the use of these substances.
The CrossFit Games Anti-Doping Program recently conducted another series of drug tests. The samples were collected by doping control officers from Drug Free Sport International in February, and analyzed at the UCLA Olympic Analytical Laboratory.
The UCLA Lab screened the samples for the full WADA Out-of-Competition Testing Panel of banned substances.
All samples were negative.
The following athletes were tested:
- Amanda Barnhart, three-time CrossFit Games athlete
- Brent Fikowski, 2017 CrossFit Games second-place finisher
- Ricky Garard, currently serving a four-year ban from the sport (through Oct. 3, 2021) after supplying a urine sample after the 2017 CrossFit Games that contained the selective androgen receptor modulator (SARM) testolone and the metabolic modulator endurobol. SARMs are classified as anabolic agents and this metabolic modulator is classified as a beta-2 agonist.
- Laura Horváth, 2018 CrossFit Games second-place finisher
- Samuel Kwant, 2020 CrossFit Games second-place finisher
- Chandler Smith, 2020 CrossFit Games sixth-place finisher
- Patrick Vellner, three-time CrossFit Games podium finisher